Tag: pharmaceuticals
-
Boehringer Ingelheim Licenses RNA Lung Cancer Immunotherapy
19 September 2014. The pharmaceutical company Boehringer Ingelheim is licensing from biopharmaceutical enterprise CureVac a vaccine based on RNA to generate an immune response for treating lung cancer. The deal has a total potential value to CureVac of €465 million ($US 597 million). CureVac, in Tübingen, Germany, develops vaccines and treatments based on messenger RNA,…
-
Small Business Contract to Fund Cancer Drug Response Tests
18 September 2014. National Cancer Institute, part of National Institutes of Health, is funding development of lab tests using a patient’s own cancer cells to help determine the best treatments for the patient. The $1.975 million contract to biotechnology company Kiyatec Inc. in Greenville, South Carolina was awarded under the Small Business Innovation Research program,…
-
Sanofi, MyoKardia Partner on Genetic Heart Disorders
17 September 2014. The pharmaceutical company Sanofi and biopharmaceutical developer MyoKardia are collaborating on development and commercialization of three MyoKardia therapies for inherited heart diseases. The deal could earn MyoKardia as much as $200 million in milestone payments and equity investments from Sanofi. MyoKardia, in South San Francisco, California, designs small-molecule therapies for two types…
-
Early Clinical Trial to Test Leukemia Antibody Safety
17 September 2014. An early stage clinical trial at University of California in San Diego is testing the safety of an antibody that in lab animals decreases the number of chronic lymphocytic leukemia cells, the most common form of leukemia among adults. The study is led by UC-San Diego medical school professor Thomas Kipps, who…
-
Lilly, AstraZeneca Collaborate on Alzheimer’s Drug
16 September 2014. The pharmaceutical companies Eli Lilly and Company and AstraZeneca will jointly develop a drug to treat Alzheimer’s disease, currently in early-stage clinical trials. In the $500 million deal, Lilly is licensing research and development conducted so far by AstraZeneca, with the companies dividing up further clinical development, commercialization, and manufacturing of the…
-
Calico Licenses Neurodegenerative Disease Compounds
11 September 2014. California Life Company, better known as Calico, is licensing for development compounds shown to protect nerve cells in lab animals against degeneration and injury. Financial terms of the deal between Southwestern Medical Center and 2M Company in Dallas, with Calico, a one-year old company backed by Google, were not disclosed. A paper…
-
Inappropriate Antibiotic Use Costing U.S. $163 Million
11 September 2014. A review of hospital records over 4 years identifies widespread overuse of antibiotics, leading to an estimated $163 million in annual avoidable costs in the U.S. The study by analysts from Premier, a corporate health care industry alliance in Charlotte, North Carolina, and Centers for Disease Control and Prevention in Atlanta appears…
-
U.S. Patent Awarded for Freeze-Dried Vaccine Formulation
9 September 2014. The technology making possible production and shipping of vaccines in a stable freeze-dried state received U.S. patent protection. Patent no. 8,808,710 was awarded last month by the U.S. Patent and Trademark Office to four inventors and assigned to University of Colorado. Soligenix Inc. in Princeton, New Jersey licensed the technology from University…
-
Grant Funding Crowdsourced Multiple Sclerosis Drug Trial
8 September 2014. A grant from a National Institutes of Health agency is funding a crowdsourced clinical trial of a generic blood pressure drug to help treat multiple sclerosis. The $1.4 million grant from National Center for Advancing Translational Sciences (NCATS) is supporting an intermediate stage clinical study by Transparency Life Sciences LLC, a drug…
-
Synthetic Platelet-Like Particles Developed, Tested
8 September 2014. Biomedical engineers and medical researchers designed and tested in the lab a new type of synthetic particle that acts like natural blood platelets to help heal bleeding. The team from Georgia Institute of Technology and Emory University medical school, both in Atlanta, published its findings yesterday in the journal Nature Materials (paid…